Volume 4 Issue 7 - 2020
Diabetes and Covid 19: Current Status!
Carmine Finelli1,2*
1Department of Internal Medicine, Ospedale Cav. R. Apicella - ASL Napoli 3 Sud, Via di Massa, Pollena, Napoli, Italy
2Covid Hospital Boscotrecase - ASL Napoli 3 Sud, Via Lenza, Boscotrecase, Napoli, Italy
*Corresponding Author: Carmine Finelli, Department of Internal Medicine, Ospedale Cav. R. Apicella - ASL Napoli 3 Sud, Via di Massa, Pollena, Napoli, Italy.
Received: May 27, 2020; Published: June 30, 2020


The infection with coronavirus disease - 2019 (COVID-19) is a double risk for patients with diabetes. Diabetes has been stated to be a risk factor for the seriousness of the condition, whereas patients continue to regulate glucose in a situation of lower and more complex intake of food.

COVID-19 is caused by the coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2), which has spread rapidly to many more than 160 countries worldwide [1,2]. The mechanism for transmitting the virus is mainly through the transfer of respiratory droplets between humans [1]. The average incubation period is 5 days, accompanied by symptomatic illness lasting 1 - 2 weeks [3]. It is characterized by a wide range of symptoms including coughing, fever, myalgia and breathing problems like viral pneumonia, and respiratory failure. In the worst cases, these can lead to death [4-6]. The average duration from first hospitalizations has been 6 - 7 days [7-9]. A percentage of those infected are either without symptoms (but still infective) or who have mild symptoms [10-12].


  1. Yi Y., et al. “COVID-19: what has been learned and to be learned about the novel coronavirus disease”. International Journal of Biological Sciences 10 (2020): 1753‐1766.
  2. Finelli C. “Obesity and Covid 19: Possible Risks!”. EC Endocrinology and Metabolic Research6 (2020): 1-3.
  3. Lauer SA., et al. “The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application”. Annals of Internal Medicine 9 (2020): 577‐582.
  4. Deng Y., et al. “Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 (COVID-19) in Wuhan, China: a retrospective study”. Chinese Medical Journal (2020).
  5. Chen G., et al. “Clinical and immunological features of severe and moderate coronavirus disease 2019”. Journal of Clinical Investigation 5 (2020): 2620‐2629.
  6. Chen T., et al. “Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study”. The British Medical Journal‎ 368 (2020): m1091.
  7. Bhatraju PK., et al. “Covid-19 in Critically Ill Patients in the Seattle Region - Case Series”. The New England Journal of Medicine 21 (2020): 2012‐2022.
  8. Liang WH., et al. “Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China”. European Respiratory Journal (2020): 2000562.
  9. Liu W., et al. “Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease”. Chinese Medical Journal 9 (2020): 1032‐1038.
  10. Noh JY., et al. “Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding duration (2020).
  11. Park SW., et al. “The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak (2020): 100392.
  12. Yan X., et al. “Duration of SARS-CoV-2 viral RNA in asymptomatic carriers”. Critical Care 1 (2020): 245.
  13. Azziz-Baumgartner E., et al. “Mortality, severe acute respiratory infection, and influenza-like illness associated with influenza A (H1N1) pdm09 in Argentina, 2009”. PLoS One10 (2012): e47540.
  14. Badawi A and Ryoo SG. “Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis”. Journal of Public Health Research 3 (2016): 733.
  15. Kumar A., et al. “Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis”. Diabetology and Metabolic Syndrome 4 (2020): 535‐545.
  16. Zhou T., et al. “Role of Adaptive and Innate Immunity in Type 2 Diabetes Mellitus”. Journal of Diabetes Research (2018): 7457269.
  17. Morgan DJ., et al. “Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia”. Frontiers in Immunology 9 (2018): 2943.
  18. Wu Y., et al. “Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention”. International Journal of Medical Sciences 11 (2014): 1185‐1200.
  19. Al-Goblan AS., et al. “Mechanism linking diabetes mellitus and obesity”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 7 (2014): 587‐591.
  20. Honce R and Schultz-Cherry S. “Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution”. Frontiers in Immunology 10 (2019): 1071.
  21. Finelli C. “Obesity and immunotherapy: the surprisingly positive association!”. Immunotherapy (2020).
  22. Marillier M., et al. “Breathing at Extremes: The Restrictive Consequences of Super- and Super-Super Obesity in Men and Women”. Chest (2020).
  23. Boukhris M., et al. “Cardiovascular implications of the COVID-19 pandemic: a global perspective”. Canadian Journal of Cardiology (2020).
  24. Liu M., et al. “Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management”. Journal of Translational Internal Medicine 1 (2020): 9‐19.
  25. Furuhashi M., et al. “Potential differential effects of renin-angiotensin system inhibitors on SARS-CoV-2 infection and lung injury in COVID-19”. Hypertension Research (2020): 1‐4.
  26. Javanmard SH., et al. “Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox”. Infection Control and Hospital Epidemiology (2020): 1‐2.
  27. Hine JL., et al. “Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study”. Diabetic Medicine 4 (2017): 551‐557.
Citation: Carmine Finelli. “Diabetes and Covid 19: Current Status!". EC Diabetes and Metabolic Research 4.7 (2020): 09-12.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.